Status:
COMPLETED
Validity of Somatosensori Remediation for Postural Control in the Treatment of Ehlers-Danlos Syndrome Hypermobility Type (hEDS)
Lead Sponsor:
University Hospital, Caen
Conditions:
Ehlers-Danlos Syndrome Hypermobility Type (hEDS)
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
In the absence of a medical consensus, the current management of Ehlers-Danlos Syndrome hypermobility type (hEDS) remains very speculative That's why investigators want in this study to demonstrate th...
Eligibility Criteria
Inclusion
- For EDS patients :
- Subjects aged 18 to 40,
- SEDh patients newly diagnosed for less than 2 years according to international criteria of 2017,
- Having a Body Mass Index (BMI) of less than 30,
- Affiliated to a social security scheme,
- Having read the information document and given in writing their free and informed consent to participate in the study.
- For healthy volunteers :
- Subjects aged 18 to 40,
- Having a Body Mass Index (BMI) of less than 30,
- Having a Beigthon score \<5 (no joint hypermobility),
- Having normal muscle strength,
- Affiliated to a social security scheme,
- Having read the information document and given in writing their free and informed consent to participate in the study.
Exclusion
- For EDS patients :
- Subjects under 18,
- Proprioceptive physiotherapy (Huber 360 platform type, LPG) in progress or already performed,
- previous treatment of hEDS capable of limiting the effects of rehabilitation (e.g. orthodontics, orthoptics),
- Diagnosis of other connective tissue abnormalities,
- Earlier prescription of compression garments,
- Pregnant or lactating women,
- Lack of effective contraception during the study period for women
- Person under tutorship or curatorship, or deprived of liberty by judicial or administrative decision,
- Mental or physical impossibility to agree to participate in the study,
- Known allergy to one of the components of compression garments,
- Disabling motor impairment, or limiting the performance of motor and psychomotor tests.
- Simultaneous participation in another clinical study.
- For healthy volunteers :
- Subjects under 18,
- History of vascular, neurological, musculoskeletal or vestibular disorders,
- Having orthoptic, orthopedic or orthodontic disorders,
- Previous history or progressive disease of vascular, ophthalmological, neurological, musculoskeletal condition, or vestibular condition
- Pregnant or lactating women,
- Person under tutorship or curatorship, or deprived of liberty by judicial or administrative decision,
- Mental or physical impossibility to agree to participate in the study,
- Simultaneous participation in another clinical study.
Key Trial Info
Start Date :
May 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 25 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04020107
Start Date
May 29 2018
End Date
November 25 2022
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Caen Univerity Hospital
Caen, France